Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.50 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29528223 | 0.88 | CA1 (0.48) | TRIM24TRIM33ALDH1A1CA1CA9 | |
| SCHEMBL15066125 | 0.85 | TRIM24 (0.44) | TRIM24TRIM33ALDH1A1CA1CA9 | |
| SCHEMBL28712569 | 0.83 | CA1 (0.52) | TRIM24TRIM33ALDH1A1CA1CA9 | |
| SCHEMBL3747926 | 0.80 | — | — | |
| SCHEMBL30488 | 0.78 | — | — | |
| SCHEMBL114386 | 0.77 | — | — | |
| SCHEMBL11091514 | 0.76 | CA1 (0.64) | TRIM24TRIM33ALDH1A1CA1CA9 | |
| SCHEMBL8987498 | 0.76 | CA1 (0.44) | TRIM24TRIM33ALDH1A1CA1CA9 | |
| SCHEMBL11311761 | 0.74 | CA1 (0.50) | TRIM24TRIM33ALDH1A1CA1CA9 | |
| Cyclohexanone SCHEMBL27940331 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3649183-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| WO-2019010263-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| EP-2430140-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2012-03-21 | — | — | EP | claimed |
| WO-2010132531-A2 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2010-11-18 | — | — | WO | claimed |
| US-20100048441-A1 | Multisensory Fragrance Compositions | Givaudan Nederland Services (NL) | 2010-02-25 | — | — | US | claimed |
| EP-2134317-A1 | MULTISENSORY FRAGRANCE COMPOSITIONS | Givaudan Nederland Services B.V. (NL) | 2009-12-23 | — | — | EP | claimed |
| WO-2008107140-A1 | MULTISENSORY FRAGRANCE COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-09-12 | — | — | WO | claimed |
| US-12319647-B2 | 2-(2,4,5-trimethylcyclohex-2-en-1-yl)acetaldehyde and derivatives and their use as aroma chemicals | BASF SE (DE) | 2025-06-03 | — | — | US | disclosed |
| US-12297169-B2 | 1-alkoxyethyl-4-isobutyl-benzene as aroma ingredients | BASF SE | 2025-05-13 | — | — | US | disclosed |
| US-20250127707-A1 | FRAGRANCE FORMULATION | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250092331-A1 | COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2025-03-20 | — | — | US | disclosed |
| US-12195698-B2 | Fragrance compound providing lily of the valley fragrance characteristics, and fragranced compositions comprising the same | GIVAUDAN SA (CH) | 2025-01-14 | — | — | US | disclosed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | disclosed |
| US-20220135901-A1 | USE OF (3-ACETOXY-2,2-DIMETHYL-PROPYL) ACETATE IN COMBINATION WITH (3-HYDROXY-2,2-DIMETHYL-PROPYL) ACETATE AS AN AROMA CHEMICAL | BASF SE (DE) | 2022-05-05 | — | — | US | disclosed |
| US-20220087956-A1 | COMBINATION THERAPIES WITH DISULFIRAM | WINTER ACQUISITION SUB, INC. | 2022-03-24 | — | — | US | disclosed |
| EP-3316972-A1 | MICROCAPSULES | Givaudan S.A. (CH) | 2018-05-09 | — | — | EP | disclosed |
| US-20170360978-A1 | AQUEOUS PERFUME COMPOSITIONS AND FRESHENING PRODUCTS COMPRISING THE AQUEOUS PERFUME COMPOSITIONS CONTAINED IN PRESSURIZED PLASTIC CONTAINERS | THE PROCTER & GAMBLE COMPANY | 2017-12-21 | — | — | US | disclosed |
| WO-2017001672-A1 | MICROCAPSULES | GIVAUDAN SA (CH) | 2017-01-05 | — | — | WO | disclosed |
| EP-2013826-A2 | MODELING SYSTEMS FOR CONSUMER GOODS | The Procter and Gamble Company (US) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007122582-A2 | MODELING SYSTEMS FOR CONSUMER GOODS | THE PROCTER & GAMBLE COMPANY (US) | 2007-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12297169-B2 | 1-alkoxyethyl-4-isobutyl-benzene as aroma ingredients | EBP, DBI, DECR1 | TRIM24 1204/4885TRIM33 3507/4885ALDH1A1 28/4885 |
| US-20250127707-A1 | FRAGRANCE FORMULATION | PUF60, POLM, ADH5 | TRIM24 730/4885TRIM33 1279/4885ALDH1A1 257/4885 |
| US-12195698-B2 | Fragrance compound providing lily of the valley fragrance characteristics, and fragranced compositions comprising the same | MDH2, MDH1, TRPV1 | TRIM24 1591/4885TRIM33 3030/4885ALDH1A1 237/4885 |
| US-12319647-B2 | 2-(2,4,5-trimethylcyclohex-2-en-1-yl)acetaldehyde and derivatives and their use as aroma chemicals | ADH5, ECH1, ALG3 | TRIM24 1238/4885TRIM33 1460/4885ALDH1A1 4/4885 |
| US-20250092331-A1 | COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS | OXER1, MSMO1, IPO7 | TRIM24 1326/4885TRIM33 3161/4885ALDH1A1 903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.